13-14-dihydro-15-ketoprostaglandin-d2 has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 2 studies
2 other study(ies) available for 13-14-dihydro-15-ketoprostaglandin-d2 and Chemical-and-Drug-Induced-Liver-Injury
Article | Year |
---|---|
Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury.
Drug-induced liver injury is a growing concern for pharmaceutical companies and patients because numerous drugs have been linked to hepatotoxicity and it is the most common reason for a drug to be withdrawn. Flutamide rarely causes liver dysfunction in humans, and immune allergic reactions have been suggested in some cases. In this study, we investigated the mechanisms of flutamide-induced liver injury in BALB/c mice. Plasma alanine aminotransferase and aspartate aminotransferase levels were significantly increased 3, 6 and 9 h after flutamide (1500 mg kg⁻¹ , p.o.) administration. The biomarker for oxidative stress was not changed, but Th2-dominant immune-related factors, such as interleukin (IL)-4, IL-5, STAT6 and GATA-binding protein (GATA)-3, were induced in flutamide-administered mice. The pre-administration of monoclonal-IL-4 antibody suppressed the hepatotoxicity of flutamide. In addition, we investigated the effect of 13,14-dihydro-15-keto-PGD₂ (DK-PGD₂; 10 µg per mouse, i.p.) administration on flutamide-induced acute liver injury. Coadministration of DK-PGD₂ and flutamide resulted in a significant increase in alanine aminotransferase and a remarkable increase of macrophage inflammatory protein-2. In conclusion, we demonstrated that flutamide-induced acute liver injury is mediated by Th2-dominant immune responses in mice. Topics: Androgen Antagonists; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Cytokines; Female; Flutamide; GATA3 Transcription Factor; Gene Expression Regulation; Interleukin-4; Liver; Mice; Mice, Inbred BALB C; Oxidative Stress; Prostaglandin D2; RNA, Messenger; STAT6 Transcription Factor; Th2 Cells | 2012 |
IL-4 mediates dicloxacillin-induced liver injury in mice.
Drug-induced liver injury (DILI) is a major problem in drug development and clinical drug therapy. In most cases, the mechanisms are still unknown. It is difficult to predict DILI in humans due to the lack of experimental animal models. Dicloxacillin, penicillinase-sensitive penicillin, rarely causes cholestatic or mixed liver injury, and there is some evidence for immunoallergic idiosyncratic reaction in human. In this study, we investigated the mechanisms of dicloxacillin-induced liver injury. Plasma ALT and total-bilirubin (T-Bil) levels were significantly increased in dicloxacillin-administered (600 mg/kg, i.p.) mice. Dicloxacillin administration induced Th2 (helper T cells)-mediated factors and increased the plasma interleukin (IL)-4 level. Neutralization of IL-4 suppressed the hepatotoxicity of dicloxacillin, and recombinant mouse IL-4 administration (0.5 or 2.0 μg/mouse, i.p.) exacerbated it. Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) is a cognate receptor for prostaglandin (PG) D(2), and is suggested to be involved in Th2-dependent allergic inflammation. We investigated the effect of 13,14-Dihydro-15-keto-PGD(2) (DK-PGD(2); 10 μg/mouse, i.p.) administration on dicloxacillin-induced liver injury. DK-PGD(2)/dicloxacillin coadministration resulted in a significant increase of alanine aminotransferases and a remarkable increase of macrophage inflammatory protein 2 expression. In conclusion, to the best of our knowledge, this is the first report to demonstrate that dicloxacillin-induced liver injury is mediated by a Th2-type immune reaction and exacerbated by DK-PGD(2). Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Antibodies, Blocking; Bilirubin; Chemical and Drug Induced Liver Injury; Dicloxacillin; Female; Interleukin-4; Liver; Mice; Mice, Inbred BALB C; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Helper-Inducer; Th2 Cells | 2011 |